Bjørn H. Ebdrup
0000-0002-2590-5055
13 papers found
Refreshing results…
Long-term outcomes with haloperidol versus placebo in acutely admitted adult ICU patients with delirium
Promising translatable pharmacological interventions for body weight management in individuals with severe mental illness – a narrative review
Differential effects of age at illness onset on verbal memory functions in antipsychotic-naïve schizophrenia patients aged 12–43 years
Multimodal assessment of white matter microstructure in antipsychotic-naïve schizophrenia patients and confounding effects of recreational drug use
Phenotypic factors associated with amisulpride‐induced weight gain in first‐episode psychosis patients (from the OPT iMi SE cohort)
Sexual dysfunction and hyperprolactinemia in schizophrenia before and after six weeks of D2/3 receptor blockade – An exploratory study
Accuracy of diagnostic classification algorithms using cognitive-, electrophysiological-, and neuroanatomical data in antipsychotic-naïve schizophrenia patients
Glucagon-like peptide-1 receptor-agonists for antipsychotic-associated cardio-metabolic risk factors: a systematic review and individual participant data meta-analysis
Erratum: Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: A randomized, placebo-controlled trial
White matter maturation during 12 months in individuals at ultra-high-risk for psychosis
‘No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia’: authors' response
No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia
Postprandial prolactin suppression appears absent in antipsychotic-treated male patients
Missing publications? Search for publications with a matching author name.